Key Drivers
- Cash Conversion
- Margin Improvement
- Leverage Watch
AIAI Summary
ELV is shifting from a “slow-growth defensive insurer” to a cash-generative healthcare operator with improving margins and durable free cash flow, but the stock's upside is now primarily gated by reimbursement, CMS, and litigation outcomes—so it looks investable only if policy noise stays contained and Health OS/Carelon keep driving margin expansion.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Conversion
- •Margin Improvement
- •Leverage Watch
ELV looks fundamentally solid, with strong cash generation, improving margins, and a sustainable dividend, though leverage and intangibles temper the balance-sheet story.
Price Behavior
Key Price Behavior Insights:
- •Rebound defended
- •Range resistance
- •Volatility risk
ELV is modestly constructive over the last month, with buyers defending $384 and price reclaiming $395-$400, but $422.71 remains the key resistance and a drop back below $395 would weaken the setup.
Sharp rebound from $384.00 on 2026-06-24 to the current level shows elevated short-term volatility
Sentiment & News
Key News Insights:
- •Digital care push
- •Growth engine
- •Legal overhang
Elevance is pairing affordable-housing and digital care investments with bullish valuation and analyst support, though a CMS reimbursement lawsuit still adds a near-term overhang.
The news flow is moderately positive for ELV, with growth and margin-improvement catalysts offset by reimbursement and legal uncertainty
Similar Companies in Healthcare
Other companies in the same sector with AI ratings